Vertex Pharmaceuticals Incorporated (VRTX)
Growth
Revenue 5Y33.40%
Revenue 3Y34.86%
EPS 5Y81.78%
EPS 3Y3.30%
Dividend 5Y-
Dividend 3Y-
Capital Efficiency
ROIC29.45%
ROE28.48%
ROA19.59%
ROTA20.33%
Capital Structure
Market Cap80.93B
EV72.58B
Cash9.17B
Current Ratio4.70
Debt/Equity0.22
Net Debt/EBITDA-1.97
VRTX
Income Statement
Select a metric from the list below to chart it
Dec '90
Dec '96
Dec '02
Dec '08
Dec '14
Dec '20
| Income Statement | Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,212.0 | 580.4 | 1,032.3 | 1,702.2 | 2,488.7 | 3,047.6 | 4,162.8 | 6,205.7 | 7,574.4 | 8,700.6 | |
| Revenue % Chg. | -20.6% | -52.1% | 77.9% | 64.9% | 46.2% | 22.5% | 36.6% | 49.1% | 22.1% | 22.0% | |
| Cost of Revenue | 130.3 | 61.0 | 124.5 | 210.5 | 275.1 | 409.5 | 547.8 | 736.3 | 904.2 | 1,044.4 | |
| Cost of Revenue % Chg. | -53.5% | -53.2% | 104.2% | 69.0% | 30.7% | 48.9% | 33.7% | 34.4% | 22.8% | 21.5% | |
| Gross Profit | 1,081.7 | 519.4 | 907.8 | 1,491.7 | 2,213.5 | 2,638.1 | 3,615.1 | 5,469.4 | 6,670.2 | 7,656.2 | |
| Gross Profit % Chg. | -13.3% | -52.0% | 74.8% | 64.3% | 48.4% | 19.2% | 37.0% | 51.3% | 22.0% | 22.1% | |
| Gross Profit Margin | 89.3% | 89.5% | 87.9% | 87.6% | 88.9% | 86.6% | 86.8% | 88.1% | 88.1% | 88.0% | |
| Gross Profit Margin % Chg. | 9.3% | 0.3% | -1.7% | -0.3% | 1.5% | -2.7% | 0.3% | 1.5% | -0.1% | 0.1% | |
| R&D Expenses | 918.8 | 855.5 | 995.9 | 1,047.7 | 1,324.6 | 1,416.5 | 1,754.5 | 1,829.5 | 3,051.1 | 2,542.5 | |
| R&D Expenses % Chg. | 14.0% | -6.9% | 16.4% | 5.2% | 26.4% | 6.9% | 23.9% | 4.3% | 66.8% | -9.9% | |
| Selling, General, & Admin Expenses | 362.3 | 305.4 | 376.6 | 432.8 | 496.1 | 557.6 | 658.5 | 770.5 | 840.1 | 932.5 | |
| Selling, General, & Admin Expenses % Chg. | -17.0% | -15.7% | 23.3% | 14.9% | 14.6% | 12.4% | 18.1% | 17.0% | 9.0% | 17.0% | |
| Operating Income | -903.4 | -692.4 | -466.9 | 9.9 | 123.2 | 635.2 | 1,197.6 | 2,856.3 | 2,782.1 | 4,151.6 | |
| Operating Income % Chg. | - | 23.4% | 32.6% | - | 1140.4% | 415.4% | 88.5% | 138.5% | -2.6% | 56.7% | |
| Operating Income Margin | -74.5% | -119.3% | -45.2% | 0.6% | 5.0% | 20.8% | 28.8% | 46.0% | 36.7% | 47.7% | |
| Operating Income Margin % Chg. | - | 60.0% | 62.1% | - | 748.4% | 320.8% | 38.0% | 60.0% | -20.2% | 28.4% | |
| Total Other Income/Expenses Net | -72.7 | -42.5 | -90.9 | -77.3 | -138.9 | -34.9 | 197.4 | 260.5 | -51.7 | -125.1 | |
| Total Other Income/Expenses Net % Chg. | 393.9% | 41.6% | 114.1% | 15.0% | 79.7% | 74.9% | - | 32.0% | - | - | |
| Income Before Tax | -976.1 | -734.9 | -557.8 | -67.4 | -15.7 | 600.2 | 1,394.9 | 3,116.8 | 2,730.4 | 4,026.6 | |
| Income Before Tax % Chg. | 7784.0% | 24.7% | 24.1% | 87.9% | 76.7% | - | 132.4% | 123.4% | -12.4% | 46.5% | |
| Income Before Tax Margin | -80.5% | -126.6% | -54.0% | -4.0% | -0.6% | 19.7% | 33.5% | 50.2% | 36.0% | 46.3% | |
| Income Before Tax Margin % Chg. | 9833.5% | 57.2% | 57.3% | 92.7% | 84.1% | - | 70.1% | 49.9% | -28.2% | 20.1% | |
| Income Tax Expense | -288.6 | 7.0 | 30.4 | 16.7 | -107.3 | -1,486.9 | 218.1 | 405.2 | 388.3 | 753.3 | |
| Income Tax Expense % Chg. | - | - | 336.6% | -45.1% | - | 1285.4% | - | 85.8% | -4.2% | 31.7% | |
| Net Income | -445.0 | -738.6 | -556.3 | -112.1 | 263.5 | 2,096.9 | 1,176.8 | 2,711.6 | 2,342.1 | 3,273.2 | |
| Net Income % Chg. | 315.8% | 66.0% | 24.7% | 79.9% | - | 695.8% | -43.9% | 130.4% | -13.6% | 50.4% | |
| Net Income Margin | -36.7% | -127.2% | -53.9% | -6.6% | 10.6% | 68.8% | 28.3% | 43.7% | 30.9% | 37.6% | |
| Net Income Margin % Chg. | 423.9% | 246.5% | 57.6% | 87.8% | - | 549.9% | -58.9% | 54.6% | -29.2% | 23.3% | |
| Weighted Avg. Shares Out | 224.9 | 235.3 | 241.3 | 244.7 | 248.9 | 254.3 | 256.7 | 259.8 | 257.7 | 255.5 | |
| Weighted Avg. Shares Out % Chg. | 6.1% | 4.6% | 2.6% | 1.4% | 1.7% | 2.2% | 1.0% | 1.2% | -0.8% | -1.4% | |
| EPS | -2.0 | -3.1 | -2.3 | -0.5 | 1.1 | 8.2 | 4.6 | 10.4 | 9.1 | 12.8 | |
| EPS % Chg. | 296.0% | 58.6% | 26.4% | 80.1% | - | 677.4% | -44.4% | 127.9% | -12.9% | 52.5% | |
| Weighted Avg. Shares Out Dil | 224.9 | 235.3 | 241.3 | 244.7 | 253.2 | 259.2 | 260.7 | 263.4 | 259.9 | 258.3 | |
| Weighted Avg. Shares Out Dil % Chg. | 6.1% | 4.6% | 2.6% | 1.4% | 3.5% | 2.4% | 0.6% | 1.0% | -1.3% | -1.2% | |
| EPS Diluted | -2.0 | -3.1 | -2.3 | -0.5 | 1.0 | 8.1 | 4.5 | 10.3 | 9.0 | 12.7 | |
| EPS Diluted % Chg. | 296.0% | 58.6% | 26.4% | 80.1% | - | 677.9% | -44.3% | 128.2% | -12.4% | 52.2% | |
| Interest Income | - | - | - | - | - | - | 63.7 | 22.2 | 4.9 | 59.8 | |
| Interest Income % Chg. | - | - | - | - | - | - | - | -65.1% | -78.0% | 890.8% | |
| Interest Expense | 22.7 | 72.9 | 84.2 | 81.4 | 57.6 | 34.1 | 58.5 | 58.2 | 61.5 | 58.3 | |
| Interest Expense % Chg. | 36.5% | 220.6% | 15.6% | -3.3% | -29.3% | -40.7% | 71.5% | -0.6% | 5.8% | -7.0% | |
| EBIT | -998.8 | -807.7 | -642.0 | -148.8 | -73.2 | 566.1 | 1,400.1 | 3,080.9 | 2,673.8 | 4,028.1 | |
| EBIT % Chg. | 3586.6% | 19.1% | 20.5% | 76.8% | 50.8% | - | 147.3% | 120.0% | -13.2% | 49.7% | |
| EBIT Margin | -82.4% | -139.2% | -62.2% | -8.7% | -2.9% | 18.6% | 33.6% | 49.6% | 35.3% | 46.3% | |
| EBIT Margin % Chg. | 4545.0% | 68.9% | 55.3% | 85.9% | 66.3% | - | 81.1% | 47.6% | -28.9% | 22.6% | |
| Depreciation & Amortization | 48.4 | 63.3 | 62.3 | 61.4 | 61.4 | 72.4 | 106.9 | 109.5 | 125.6 | 143.7 | |
| Depreciation & Amortization % Chg. | 26.6% | 30.8% | -1.4% | -1.5% | -0.0% | 18.0% | 47.7% | 2.4% | 14.7% | 18.7% | |
| EBITDA | -950.5 | -744.5 | -579.7 | -87.4 | -11.8 | 638.5 | 1,507.0 | 3,190.4 | 2,799.4 | 4,171.8 | |
| EBITDA % Chg. | - | 21.7% | 22.1% | 84.9% | 86.5% | - | 136.0% | 111.7% | -12.3% | 48.3% | |
| EBITDA Margin | -78.4% | -128.3% | -56.2% | -5.1% | -0.5% | 21.0% | 36.2% | 51.4% | 37.0% | 47.9% | |
| EBITDA Margin % Chg. | - | 63.6% | 56.2% | 90.9% | 90.7% | - | 72.8% | 42.0% | -28.1% | 21.5% |